Investigation Report on Chinese Hydroxychloroquine(HCQ) Market, 2020-2024
No. of Pages: 50
Description
Hydroxychloroquine(HCQ) is an antimalarial drug. It treats malaria by killing the parasites that cause the disease. Hydroxychloroquine was listed in the United States in 1955,
|
20-Oct-2020
|
2600
|
Research Report on China Express Delivery Industry, 2020-2024
No. of Pages: 60
Description
From 2015 to 2020, the frequency of online shopping applications of Chinese Internet users increased from 56.00% to 79.7%. Online shopping has become one of
|
20-Oct-2020
|
2600
|
Investigation Report on Chinese Rituximab Market, 2020-2024
No. of Pages: 50
Description
Rituximab (Roche's trade name: MabThera/Rituxan) is a human-mouse chimeric anti-CD20 monoclonal antibody that was approved for the treatment of tumors in 1997. With the deep
|
20-Oct-2020
|
2600
|
Research Report on China's New Energy Vehicle Drive Motor Industry, 2020-2024
No. of Pages: 50
Description
With government support and technological progress, the global electric vehicle market is developing rapidly. The production volume of global electric vehicle increased rapidly from only
|
20-Oct-2020
|
2600
|
Investigation Report on Sevoflurane in China, 2020-2024
No. of Pages: 50
Description
Sevoflurane is an inhaled general anesthetic featured with rapid induction and quick wake-up of patients. It has slight inhibition on circulation, little effect on liver
|
20-Oct-2020
|
2600
|
Research Report on Chinese Deproteinized Calf Blood Extractives market 2020-2024
No. of Pages: 50
Description
Deproteinized Calf Blood Extractives, is a drug that improves the energy metabolism of cells, has aroused a wide concern at home and abroad after years
|
20-Oct-2020
|
2400
|
Investigation Report on China Entecavir Market 2020-2024
No. of Pages: 50
DesResearchaerption
The number of people infected with hepatitis B virus (HBV) exceeds 100 million in China by the end of 2019, among which 20-30 million suffering
|
30-Sep-2020
|
2600
|
Investigation Report on China Recombinant Factor Ⅷ (rFVIII) Market 2020-2024
No. of Pages: 40
DesResearchaerption
There are approximately 400,000 to 1 million people with hemophilia in the world. Among them, there are about 100,000 to 200,000 patients in China. The
|
30-Sep-2020
|
2400
|
Investigation Report on Chinese Pregabalin Market, 2020-2024
No. of Pages: 40
Pregabalin is a new-generation drug for neuralgia treatment. In Jul. 2004, it was approved by the European Union to treat some epileptic seizures in adults.
|
30-Sep-2020
|
2400
|
Investigation Report on China's Ambroxol Market, 2020-2024
No. of Pages: 50
DesResearchaerption
According to Researchaer, the incidence and case fatality rate of respiratory diseases in China are high in recent years. Following cardiovascular and cerebrovascular diseases and
|
30-Sep-2020
|
2600
|
Pre-order Enquiry
Request Free Sample
